Literature DB >> 29858962

Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.

Oğuzhan Karaosmanoğlu1, Sreeparna Banerjee2, Hülya Sivas3.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. Complete epithelial to mesenchymal transition (EMT) has long been considered as a crucial step for metastasis initiation. It has, however, become apparent that many carcinoma cells can metastasize without complete loss of epithelial traits or with incomplete gain of mesenchymal traits, i.e., partial EMT. Here, we aimed to determine the similarities and differences between complete and partial EMT through over-expression of the EMT-associated transcription factor Slug in different HCC-derived cell lines.
METHODS: Slug over-expressing HCC-derived HepG2 and Huh7 cells were assessed for their EMT, chemo-resistance and stemness features using Western blotting, qRT-PCR, neutral red uptake, doxorubicin accumulation and scratch wound healing assays. We also collected conditioned media from Slug over-expressing HCC cells and analyzed its exosomal protein content for the presence of chemo-resistance and partial EMT markers using MALDI-TOF/TOF and ELISA assays, respectively.
RESULTS: We found that Slug over-expression resulted in the induction of both complete and partial EMT in the different HCC-derived cell lines tested. Complete EMT was characterized by downregulation of E-cadherin and upregulation of ZEB2. Partial EMT was characterized by upregulation of E-cadherin and downregulation of vimentin and ZEB2. Interestingly, we found that Slug induced chemo-resistance through downregulation of the ATP binding cassette (ABC) transporter ABCB1 and upregulation of the ABC transporter ABCG2, as well as through expression of CD133, a stemness marker that exhibited a similar expression pattern in cells with either a complete or a partial EMT phenotype. In addition, we found that Slug-mediated partial EMT was associated with enhanced exosomal secretion of post-translationally modified fibronectin 1 (FN1), collagen type II alpha 1 (COL2A1) and native fibrinogen gamma chain (FGG).
CONCLUSIONS: From our data we conclude that the exosomal proteins identified may be considered as potential non-invasive biomarkers for chemo-resistance and partial EMT in HCC.

Entities:  

Keywords:  Chemo-resistance; Collagen type II alpha 1 (COL2A1); Exosomes; Fibrinogen gamma chain (FGG); Fibronectin 1 (FN1); Hepatocellular carcinoma; Non-invasive biomarkers; Partial EMT

Mesh:

Substances:

Year:  2018        PMID: 29858962     DOI: 10.1007/s13402-018-0384-6

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  71 in total

1.  Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.

Authors:  Upender Manne; Trafina Jadhav; Balananda-Dhurjati Kumar Putcha; Temesgen Samuel; Shivani Soni; Chandrakumar Shanmugam; Esther A Suswam
Journal:  Curr Colorectal Cancer Rep       Date:  2016-09-20

Review 2.  Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

Authors:  Jason J Christiansen; Ayyappan K Rajasekaran
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

3.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

4.  Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.

Authors:  W Song; H Li; K Tao; R Li; Z Song; Q Zhao; F Zhang; K Dou
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

5.  Neutral red uptake assay for the estimation of cell viability/cytotoxicity.

Authors:  Guillermo Repetto; Ana del Peso; Jorge L Zurita
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

6.  MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.

Authors:  Jan Pinkas; Philip Leder
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

7.  Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition.

Authors:  Hongyuan Chang; Yuwei Liu; Mengzhu Xue; Haiyue Liu; Shaowei Du; Liwen Zhang; Peng Wang
Journal:  Nucleic Acids Res       Date:  2016-02-28       Impact factor: 16.971

8.  Inhibition of Snail Family Transcriptional Repressor 2 (SNAI2) Enhances Multidrug Resistance of Hepatocellular Carcinoma Cells.

Authors:  Xin-Yu Zhao; Lei Li; Xiao-Bo Wang; Rong-Jie Fu; Ya-Ping Lv; Wei Jin; Chao Meng; Guo-Qiang Chen; Lei Huang; Ke-Wen Zhao
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

9.  Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.

Authors:  Min Zheng; Ya-ping Jiang; Wei Chen; Kai-de Li; Xin Liu; Shi-yu Gao; Hao Feng; Sha-sha Wang; Jian Jiang; Xiang-rui Ma; Xiao Cen; Ya-jie Tang; Yu Chen; Yun-feng Lin; Ya-ling Tang; Xin-hua Liang
Journal:  Oncotarget       Date:  2015-03-30

10.  Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Authors:  Xiaofeng Zheng; Julienne L Carstens; Jiha Kim; Matthew Scheible; Judith Kaye; Hikaru Sugimoto; Chia-Chin Wu; Valerie S LeBleu; Raghu Kalluri
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more
  21 in total

1.  Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.

Authors:  Sanghoon Lee; Yiheng Hu; Suet Kee Loo; Ying Tan; Rohit Bhargava; Michael T Lewis; Xiao-Song Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

2.  Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.

Authors:  Chao Ye; Xiaoqian Zhang; Xinyu Chen; Qingyi Cao; Xiaobing Zhang; Yanwen Zhou; Wenxin Li; Liangjie Hong; Haiyang Xie; Xiaoli Liu; Hongcui Cao; Ying-Jie Wang; Bo Kang
Journal:  Cell Oncol (Dordr)       Date:  2019-12-17       Impact factor: 6.730

Review 3.  Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.

Authors:  Federico Rossari; Cristina Zucchinetti; Gabriele Buda; Enrico Orciuolo
Journal:  Cell Oncol (Dordr)       Date:  2019-08-07       Impact factor: 6.730

4.  COL8A1 Predicts the Clinical Prognosis of Gastric Cancer and Is Related to Epithelial-Mesenchymal Transition.

Authors:  Yali She; Xiaowen Zhao; Pingfan Wu; Ling Xue; Shengfang Wan; Lei Zhang; Changtian Li; Hui Cai; Yaling Li
Journal:  Biomed Res Int       Date:  2022-06-21       Impact factor: 3.246

Review 5.  Partial EMT in head and neck cancer biology: a spectrum instead of a switch.

Authors:  Ananya Pal; Thomas F Barrett; Rachel Paolini; Anuraag Parikh; Sidharth V Puram
Journal:  Oncogene       Date:  2021-07-08       Impact factor: 8.756

6.  HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma.

Authors:  Bor-Hwang Kang; Chih-Wen Shu; Jian-Kang Chao; Cheng-Hsin Lee; Ting-Ying Fu; Huei-Han Liou; Luo-Ping Ger; Pei-Feng Liu
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

Review 7.  Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.

Authors:  Qin Wu; Lingyun Zhou; Duoduo Lv; Xia Zhu; Hong Tang
Journal:  J Hematol Oncol       Date:  2019-05-29       Impact factor: 17.388

8.  FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition.

Authors:  Xiang Zhang; Fei Wang; Yanbing Huang; Kun Ke; Bixing Zhao; Lihong Chen; Naishun Liao; Lei Wang; Qin Li; Xiaolong Liu; Yingchao Wang; Jingfeng Liu
Journal:  Cancer Manag Res       Date:  2019-02-19       Impact factor: 3.989

9.  Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence.

Authors:  Ombretta Repetto; Federica Lovisa; Caterina Elia; Daniel Enderle; Filippo Romanato; Salvatore Buffardi; Alessandra Sala; Marta Pillon; Agostino Steffan; Roberta Burnelli; Lara Mussolin; Maurizio Mascarin; Valli De Re
Journal:  Diagnostics (Basel)       Date:  2021-05-21

10.  Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells.

Authors:  Chang-Cheng Zhao; Wen-Wei Yu; Ying-Jie Qi; Liang-Fei Xu; Zi-Ran Wang; Ya-Wen Qiang; Fan Ma; Xiao-Ling Ma
Journal:  Anticancer Drugs       Date:  2020-03       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.